Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/MK-2206> ?p ?o }
Showing triples 1 to 38 of
38
with 100 triples per page.
- MK-2206 abstract "MK-2206 is a drug candidate being investigated to help treat cancer. Its chemical formula is C25H21N5O. It acts as an allosteric AKT inhibitor.It is a highly selective inhibitor of pan-Akt, namely, of all three Akt isoforms Akt1, Akt2, and Akt3.It is intended to be used with other cancer therapies that advanced tumours may become resistant to.".
- MK-2206 iupacName "8-[4-(1-Aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one".
- MK-2206 thumbnail MK-2206.svg?width=300.
- MK-2206 wikiPageID "48532500".
- MK-2206 wikiPageLength "2672".
- MK-2206 wikiPageOutDegree "7".
- MK-2206 wikiPageRevisionID "704263686".
- MK-2206 wikiPageWikiLink AKT1.
- MK-2206 wikiPageWikiLink AKT2.
- MK-2206 wikiPageWikiLink AKT3.
- MK-2206 wikiPageWikiLink Allosteric_regulation.
- MK-2206 wikiPageWikiLink Category:Experimental_cancer_drugs.
- MK-2206 wikiPageWikiLink Category:Protein_kinase_inhibitors.
- MK-2206 wikiPageWikiLink Protein_kinase_B.
- MK-2206 wikiPageWikiLinkText "MK-2206".
- MK-2206 imagefile "MK-2206.svg".
- MK-2206 imagesize "200".
- MK-2206 iupacname "8".
- MK-2206 wikiPageUsesTemplate Template:Chembox.
- MK-2206 wikiPageUsesTemplate Template:Chembox_Hazards.
- MK-2206 wikiPageUsesTemplate Template:Chembox_Identifiers.
- MK-2206 wikiPageUsesTemplate Template:Chembox_Properties.
- MK-2206 wikiPageUsesTemplate Template:Pharma-stub.
- MK-2206 wikiPageUsesTemplate Template:Reflist.
- MK-2206 subject Category:Experimental_cancer_drugs.
- MK-2206 subject Category:Protein_kinase_inhibitors.
- MK-2206 hypernym Candidate.
- MK-2206 type ChemicalCompound.
- MK-2206 type ChemicalSubstance.
- MK-2206 type Person.
- MK-2206 type ChemicalObject.
- MK-2206 type Thing.
- MK-2206 type Q11173.
- MK-2206 comment "MK-2206 is a drug candidate being investigated to help treat cancer. Its chemical formula is C25H21N5O. It acts as an allosteric AKT inhibitor.It is a highly selective inhibitor of pan-Akt, namely, of all three Akt isoforms Akt1, Akt2, and Akt3.It is intended to be used with other cancer therapies that advanced tumours may become resistant to.".
- MK-2206 label "MK-2206".
- MK-2206 wasDerivedFrom MK-2206?oldid=704263686.
- MK-2206 depiction MK-2206.svg.
- MK-2206 isPrimaryTopicOf MK-2206.